Expression of the receptor for advanced glycation end products in acquired reactive perforating collagenosis.
Indian J Dermatol Venereol Leprol 2017 Apr 27. Epub 2017 Apr 27.
Department of Dermatovenereology, Ataturk Training and Research Hospital, Ankara, Turkey.
Background: Acquired reactive perforating collagenosis (ARPC) is a rare skin disorder characterized by transepidermal elimination of dermal collagen. There is little data regarding the pathogenesis of ARPC. The receptor for advanced glycation end products (RAGE) is a multiligand transmembrane receptor that plays an important role in inflammatory responses and may be involved in the pathogenesis of ARPC. Read More